Bronte Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Herbalife
HLF
|
+$17.1M |
| 2 |
Sotera Health
SHC
|
+$5.2M |
| 3 |
Sociedad Química y Minera de Chile
SQM
|
+$4.34M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$3.83M |
| 5 |
Visa
V
|
+$2.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.39M |
| 2 |
Vir Biotechnology
VIR
|
+$3.26M |
| 3 |
Newmont
NEM
|
+$1.37M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$958K |
| 5 |
Altria Group
MO
|
+$896K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.89% |
| 2 | Communication Services | 10.45% |
| 3 | Consumer Staples | 10.21% |
| 4 | Healthcare | 6.35% |
| 5 | Materials | 3.2% |
Similar funds
Bronte Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Bronte Capital Management held 30 positions worth $1.52B, up 11% from $1.37B the previous quarter. Its ten largest holdings account for 87% of the portfolio.
Bronte Capital Management deployed $202M of net new capital in Q4 2021, opening 3 new positions and adding to 10 existing holdings. Its largest new stake was Sociedad Química y Minera de Chile: 75,627 shares worth $3.81M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Communication Services and Consumer Staples.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $3.39M trimmed.
- Bronte Capital Management's largest Q4 2021 buy was Sociedad Química y Minera de Chile: 75,627 shares worth $3.81M.
- Bronte Capital Management added most to Herbalife in Q4 2021, an estimated $17.1M increase.
- Bronte Capital Management's biggest Q4 2021 reduction was Alphabet (Google) Class C, cutting an estimated $3.39M.
- Bronte Capital Management fully exited Vir Biotechnology in Q4 2021, selling an estimated $3.26M.
- Bronte Capital Management's ten largest holdings make up 87% of its $1.52B portfolio in Q4 2021.
- Bronte Capital Management opened 3 new positions and closed 1 in Q4 2021.
- Bronte Capital Management's portfolio value rose 11% quarter-over-quarter to $1.52B.
Based on Bronte Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.